# Junta clínica — PT-pseudo_668c2a174afc (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_668c2a174afc",
  "pid": "PT-pseudo_668c2a174afc",
  "task": 1,
  "psa": 7.93,
  "age": 74,
  "months": 3,
  "pirads": "5",
  "psad": 0.267,
  "psav": 1.17,
  "psap": 5.7,
  "vol": 29.7,
  "dre": "Normal",
  "bx": "None",
  "cspca": 0.72964996,
  "medhx": "Not reported",
  "meds": "None",
  "notes": "PSA 7.93 ng/mL. PI-RADS 5. PSAD 0.27. Prostate volume 30 mL. csPCa 0.73.",
  "pmhx": [],
  "allergies": [],
  "vitals": {
    "weight": "64 kg",
    "height": "174 cm",
    "bmi": "21.1",
    "bp": "141/69 mmHg",
    "hr": "80 bpm",
    "smoking": "Non-smoker",
    "last_dental": "1 yr ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "22 Jan 2025",
  "enc_ref": "Dr. F. de Boer (GP)",
  "enc_type": "Follow-up - PSA + MRI",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Current assessment focuses on interpreting the most recent multiparametric MRI alongside updated PSA metrics."
    },
    {
      "s": "History",
      "t": "At seventy-four years of age, this retired bank clerk is divorced and shares a household with his partner. He maintains a strict non-smoker status and abstains completely from alcohol, supplementing that routine with light home-based resistance training twice weekly. Medical history reveals zero comorbidities and no active prescriptions. Lower urinary tract symptoms are entirely absent, registering a zero IPSS score, while he explicitly denies erectile dysfunction or hematuria. Routine health maintenance includes biannual dental examinations, a dermatology screening last month for actinic keratosis surveillance, and the recent completion of a six-session physiotherapy program targeting stable mechanical lower back pain. Travel to this facility necessitates a train commute exceeding one hour. Prior biopsy history registers as negative."
    },
    {
      "s": "Physical examination",
      "t": "Digital rectal examination demonstrates a symmetrically smooth gland with uniform consistency and absolutely no palpable asymmetry or discrete nodularity. Vital signs remain stable, and general inspection shows a well-appearing gentleman free of acute distress. Palpation of the abdomen yields a soft, non-tender contour with no detectable masses or lymphadenopathy."
    }
  ],
  "occupation": "retired bank clerk",
  "marital": "Divorced",
  "living": "Lives with partner",
  "next_of_kin": "Spouse / partner (primary contact)",
  "recent_other": [
    "Dental — biannual check-up",
    "Physiotherapy — lower back, six sessions",
    "Dermatology — actinic keratosis check"
  ],
  "alcohol": "0 units / week (alcohol-free)",
  "exercise": "Light weight-training at home, 2x/week",
  "ipss": "IPSS score: 0/35 (mild LUTS)",
  "admin": "Patient travels 60+ min by train to clinic; allow buffer.",
  "mri_hospital": "Amsterdam UMC (location VUmc)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_668c2a174afc
Task: 1

Encounter: Urology - outpatient on 22 Jan 2025.
Referrer: Dr. F. de Boer (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 74-year-old male
  - PSA: 7.93 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.267 ng/mL²
  - PSA velocity: 1.17 ng/mL/yr
  - Prior PSA: 5.7 ng/mL
  - Prostate volume: 29.7 mL
  - Months since last PSA: 3
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.72964996 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 7.93 ng/mL. PI-RADS 5. PSAD 0.27. Prostate volume 30 mL. csPCa 0.73.

Vitals: weight 64 kg, height 174 cm, BMI 21.1, BP 141/69 mmHg, HR 80 bpm. Smoking: Non-smoker.

Chief complaint: Current assessment focuses on interpreting the most recent multiparametric MRI alongside updated PSA metrics.

History: At seventy-four years of age, this retired bank clerk is divorced and shares a household with his partner. He maintains a strict non-smoker status and abstains completely from alcohol, supplementing that routine with light home-based resistance training twice weekly. Medical history reveals zero comorbidities and no active prescriptions. Lower urinary tract symptoms are entirely absent, registering a zero IPSS score, while he explicitly denies erectile dysfunction or hematuria. Routine health maintenance includes biannual dental examinations, a dermatology screening last month for actinic keratosis surveillance, and the recent completion of a six-session physiotherapy program targeting stable mechanical lower back pain. Travel to this facility necessitates a train commute exceeding one hour. Prior biopsy history registers as negative.

Physical examination: Digital rectal examination demonstrates a symmetrically smooth gland with uniform consistency and absolutely no palpable asymmetry or discrete nodularity. Vital signs remain stable, and general inspection shows a well-appearing gentleman free of acute distress. Palpation of the abdomen yields a soft, non-tender contour with no detectable masses or lymphadenopathy.

Patient info: retired bank clerk; Divorced; Lives with partner.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 0 units / week (alcohol-free); exercise Light weight-training at home, 2x/week; IPSS score: 0/35 (mild LUTS).

Recent other appointments: Dental — biannual check-up; Physiotherapy — lower back, six sessions; Dermatology — actinic keratosis check.
Admin: Patient travels 60+ min by train to clinic; allow buffer.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.87
  uncertainty  +/- 0.05 epistemic (95% band 0.78-0.97); among patients I cannot tell apart the outcome was 0.55 of 1.00 mixed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

What moved me most, across the labelled series: prior positive biopsy, PI-RADS >= 4, no prior biopsy, pmhx_hypercholesterolaemia, suspicious DRE, number of comorbidities. I read 39 variables, all
from the panel — nothing from the mpMRI prose, the PSA trajectory, the previous notes or the
laboratory. Out-of-fold over 91 labelled cases: AUC 0.758, balanced
accuracy 0.625.

The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: never biopsied. My criterion answers BIOPSY.

The criterion: sample when the mpMRI shows a PI-RADS 3 or higher lesion; defer at PI-RADS 1-2. In the labelled series this criterion matched the reading urologist in 24 of 24 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 24 labelled men in this same situation (None prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 0.41: PI-RADS 5, PSA 6.77, PSAD 0.239, age 74, DRE Normal -> BIOPSY (clear). He wrote: "74yr where it was decided to do MRI to assess potential PCa. The MRI shows high suspicion of PCa, and thus should be biopsied. Why was he not biopsied when the first MRI…"
  2. distance 0.90: PI-RADS 5, PSA 12.0, PSAD 0.411, age 71, DRE Normal -> BIOPSY (borderline). He wrote: "P5 in 71 years old patient with no major comorbidities"
  3. distance 1.27: PI-RADS 5, PSA 11.4, PSAD 0.209, age 70, DRE Normal -> BIOPSY (clear). He wrote: "P5 with rapid increasing PSA"

PRECEDENT: BIOPSY (weighted vote 1.00 for biopsy). Distance-weighted precedent is strong here (0.92 leave-one-out).

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 24 labelled traces in this situation (None prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.
WHAT HE WEIGHS: bx=noted, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted.
HOW SURE HE USUALLY IS: clear.

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines link PI-RADS scores to the indication for biopsy, noting that a PI-RADS threshold of $\ge 3$ is used to trigger biopsy. The guideline also suggests that MRI-directed US-guided prostate biopsy is now the standard of care.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
Expert 1's suggestion of biopsy is not decisive because the guideline does not account for the patient's prior biopsy status, which is a critical variable. The cohort criterion explicitly states that the criterion matched the reading urologist in 24 of 24 cases in this exact situation.

WHAT WE STILL NEED
The guideline requires the PI-RADS score, which is known to be 5, which is above the threshold of 3. The prior biopsy status is known to be 'None', which is a critical factor in the guideline's context. The PSA density is known to be $0.267 \text{ ng/mL}^2$, which is above the $0.20 \text{ ng/mL/cc}$ threshold mentioned in the guideline. The prior biopsy status is known to be 'None', which is a critical factor in the guideline's context. The PI-RADS score is known to be 5, which is above the threshold of 3.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case strongly suggests biopsy based on the PI-RADS score and the cohort criterion, but we must establish the context of the prior biopsy status as per the EAU guidelines.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> What is the lesion size and zone of the PI-RADS 5 lesion?
  psa_trend (get_psa_trend) -> What is the trend of the serial PSA values?
  previous_notes (get_previous_notes) -> What is the management context regarding prior biopsy, surveillance protocol, and planned treatment?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the GRADE (Gleason or ISUP) of the prior biopsy, given the patient has no prior biopsy?

On the plan itself: Dropped 1 question(s) that asked for a value already printed on the panel: "Does the PSA density of $0.267 ext{ ng/mL}^2$ meet the threshold mentioned in the EAU guideline?".

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
The lesion size and zone of the PI-RADS 5 lesion is "spanning roughly 14 x 11 x 10 mm" in the "right anterior mid-apex zone".
psa_trend
The trend of the serial PSA values is a decrease from 5.5 ng/mL in "Dec 2023" to 0.6 ng/mL in "Jul 2024", followed by a rise to 7.93 ng/mL in "Jan 2025".
previous_notes
The management context regarding prior biopsy, surveillance protocol, and planned treatment is: "Because values have climbed steadily since late 2022, a multiparametric MRI was commissioned through local radiology to define glandular architecture before any procedural interventions were entertained."

WHAT I DID NOT OPEN
I did not open the laboratory_results or the family-history anamnesis because the required information regarding the PSA density threshold and family history was not explicitly requested by the moderator or the plan.

WHAT THIS SUPPORTS
Findings that argue FOR sampling this patient now:
PI-RADS score is 5, which is above the threshold of 3 according to the EAU guideline.
The cohort criterion matched the reading urologist in 24 of 24 cases in this exact situation.

Findings that argue AGAINST sampling this patient now:
The previous notes state that the MRI was commissioned "before any procedural interventions were entertained."

WHERE THIS LEANS
The evidence strongly points toward biopsy due to the PI-RADS 5 score and the cohort criterion match, despite the prior note suggesting a pre-procedural assessment.
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: INDETERMINATE (uncertain). Last value 7.93 ng/mL over 5 points spanning 25 months; velocity +0.81 ng/mL per year; no meaningful doubling time.
PROJECTION at 6 months: 9.7 ng/mL, conformal 95% band 2.8-33.9.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.82
  uncertainty  +/- 0.06 epistemic (95% band 0.71-0.93), of which 0.00 comes from values that had to be imputed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

What moved me most across the labelled series: prior positive biopsy, no prior biopsy, free PSA < 15%, DWI restriction in the report, lesion >= 15 mm in the report, suspicious DRE. Out-of-fold AUC 0.794. I am the only expert that has read the report's wording, and I still cannot see the prior grade or the
surveillance history: those are in the notes, and the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.87  ('firm' tier)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.82  ('firm' tier, fusion_nolab)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=1.00  (k=3 precedents)
  EXPERT-COHORT      BIOPSY  (rule pirads_ge_3)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: cohort criterion (pirads_ge_3) — carried by EXPERT-COHORT.
PANEL ANSWER: BIOPSY. It matched the reading urologist in 24 of 24 labelled cases in exactly this situation (never biopsied).

Confidence the trace model expects here: clear. Weights it expects: bx=noted, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents opened—radiology_report, psa_trend, and previous_notes—address the moderator's questions to the extent possible. The registrar retrieved information regarding the PI-RADS 5 lesion size, the PSA trend, and the management context regarding prior biopsy.

ALIGNMENT WITH THE PANEL
The retrieved evidence strongly aligns with the PANEL-PROTOCOL's answer of BIOPSY, as the PI-RADS score of 5 triggered the cohort criterion, which the panel explicitly states fired.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the GRADE (Gleason or ISUP) of the prior biopsy, given the patient has no prior biopsy? This question remains unanswered, as the registrar did not retrieve information regarding the prior biopsy grade.

WHAT CARRIES WEIGHT, AND WHY
The PI-RADS score of 5 is the most decisive variable as it directly triggers the cohort criterion, which the panel confirms. The PSA trend and the MRI lesion size provide supporting context for the suspicion.

MY SUGGESTION TO THE CHAIR
Given the strong alignment of the cohort criterion and the high expert consensus, I suggest proceeding with biopsy. The decision rests on the lack of a prior biopsy grade, which is a known gap.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

Biopsy is recommended because the PI-RADS score of 5 directly triggered the cohort criterion, which the panel protocol confirms based on its track record. This decision is supported by the high consensus from the structured expert and the library precedents, despite the lack of a prior biopsy grade. The evidence converged on biopsy due to the high suspicion indicated by the imaging findings.

What carried weight: bx=noted, age=important, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted
Documents this conference opened: radiology_report, psa_trend, previous_notes
